Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03237780
What this trial is testing

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+21 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Looking for participantsNCT04428554
What this trial is testing

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

Who this might be right for
Urothelial Bladder Cancer
Institut Claudius Regaud 130
Not applicableEnded earlyNCT05052372
What this trial is testing

Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Who this might be right for
Bladder CancerUrothelial CarcinomaTransitional Cell Carcinoma+10 more
xCures 2
Large-scale testing (Phase 3)Active Not RecruitingNCT05911295
What this trial is testing

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Who this might be right for
Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer 412
Not applicableActive Not RecruitingNCT05946993
What this trial is testing

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

Who this might be right for
SurvivorshipProstate CancerKidney Cancer+3 more
University College Cork 72
Testing effectiveness (Phase 2)Study completedNCT00694915
What this trial is testing

Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder

Who this might be right for
Bladder Cancer
Cadila Pharnmaceuticals 122
Testing effectiveness (Phase 2)Study completedNCT04383743
What this trial is testing

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Stage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma
University of Washington 17
Not applicableStudy completedNCT02643043
What this trial is testing

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

Who this might be right for
Urothelial CarcinomaBladder CancerUrethral Cancer+1 more
Matthew Milowsky, MD 219
Early research (Phase 1)Ended earlyNCT02767921
What this trial is testing

SEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaRecurrent Bladder CarcinomaStage I Prostate Cancer+7 more
University of Southern California 2
Not applicableLooking for participantsNCT07059884
What this trial is testing

Distance-Based Exercise to Preserve Function and Prevent Disability

Who this might be right for
Localized Malignant Solid NeoplasmAnal CancerBladder (Urothelial, Transitional Cell) Cancer+16 more
Alliance for Clinical Trials in Oncology 104
Not applicableStudy completedNCT01180478
What this trial is testing

Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer

Who this might be right for
Bladder Cancer
Clinical Research Office of the Endourological Society 965
Testing effectiveness (Phase 2)Looking for participantsNCT05239624
What this trial is testing

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT03980041
What this trial is testing

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

Who this might be right for
Bladder CancerUrothelial CarcinomaSolid Tumor+1 more
Infinity Pharmaceuticals, Inc. 49
Not applicableStudy completedNCT06193941
What this trial is testing

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

Who this might be right for
Bladder CancerUrothelial Carcinoma
Zhongnan Hospital 400
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Testing effectiveness (Phase 2)UnknownNCT05418309
What this trial is testing

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center Study

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 63
Testing effectiveness (Phase 2)Study completedNCT00556621
What this trial is testing

Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer

Who this might be right for
Bladder Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 14
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT03744793
What this trial is testing

Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma With Glandular DifferentiationInfiltrating Bladder Urothelial Carcinoma With Squamous Differentiation+4 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00003640
What this trial is testing

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 73
Next Page
18